Literature DB >> 6896291

The actions of leukotrienes C4 and D4 on guinea-pig isolated hearts.

L G Letts, P J Piper.   

Abstract

1 Infusions of leukotrienes C4 (LTC4) and LTD4 (5 min; 4 X 10-10-2 X 10-8 M) produced dose-dependent decreases in coronary flow in Langendorff preparations of guinea-pig isolated heats. 2 LTC 4 was more active than LTD4 and produced greater reduction in coronary flow 3 LTC4 and LTD4 also caused reduction in contractility in perfused hearts but not in isolated atria or driven ventricular strips. 4 There was a greater reduction in contractility to LTD4 compared with LTC4 at doses which produced approximately 50% reduction in coronary flow. 5 Indomethacin (1.4 X 10-5 M) inhibited the effects of LTC4 but only reduced the initial LTD4- induced effects. 6 The effects of FPL 55712 (3.8 X 10-6 M) were similar to those of indomethacin. 7 LTC4 and LTD4 may therefore contribute to the abnormalities of cardiac function that occur in immediate hypersensitivity reactions, particularly reduction in coronary flow.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6896291      PMCID: PMC2068756          DOI: 10.1111/j.1476-5381.1982.tb09203.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  26 in total

1.  The release of histamine and formation of a slow-reacting substance (SRS-A) during anaphylactic shock.

Authors:  W E BROCKLEHURST
Journal:  J Physiol       Date:  1960-06       Impact factor: 5.182

2.  The occurrence of a lipid-soluble smooth-muscle stimulating principle ('SRS') in anaphylactic reaction.

Authors:  N CHAKRAVARTY
Journal:  Acta Physiol Scand       Date:  1960-03-18

3.  Non-immunological release of slow-reacting substance from guinea-pig lungs.

Authors:  P J Piper; J P Seale
Journal:  Br J Pharmacol       Date:  1979-09       Impact factor: 8.739

4.  The effect of leukotrienes C4 and D4 on the microvasculature of guinea-pig skin.

Authors:  M J Peck; P J Piper; T J Williams
Journal:  Prostaglandins       Date:  1981-02

5.  Drugs which inhibit prostaglandin biosynthesis.

Authors:  R J Flower
Journal:  Pharmacol Rev       Date:  1974-03       Impact factor: 25.468

6.  Release of 15-keto-13, 14-dihydro-thromboxane B2 and prostaglandin D2 during anaphylaxis as measured by radioimmunoassay.

Authors:  H Anhut; B A Peskar; W Bernauer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-12       Impact factor: 3.000

7.  Prostaglandins and cardiac anaphylaxis.

Authors:  R Levi; G Allan; J H Zavecz
Journal:  Life Sci       Date:  1976-06-01       Impact factor: 5.037

8.  Prostaglandin, slow-reacting substance, and histamine release from anaphylactic guinea-pig hearts, and its pharmacological modification.

Authors:  R Liebig; W Bernauer; B A Peskar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

9.  Transformation of arachidonic acid and prostaglandin endoperoxides by the guinea pig heart. Formation of RCS and prostacyclin.

Authors:  K Schrör; S Moncada; F B Ubatuba; J R Vane
Journal:  Eur J Pharmacol       Date:  1978-01-01       Impact factor: 4.432

10.  Thromboxane and prostacyclin release during cardiac immediate hypersensitivity reactions in vitro.

Authors:  G Allan; R Levi
Journal:  J Pharmacol Exp Ther       Date:  1981-04       Impact factor: 4.030

View more
  23 in total

Review 1.  Leukotriene receptors.

Authors:  S E Dahlén
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

2.  Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT(2)) receptor.

Authors:  F Wunder; H Tinel; R Kast; A Geerts; E M Becker; P Kolkhof; J Hütter; J Ergüden; M Härter
Journal:  Br J Pharmacol       Date:  2010-05       Impact factor: 8.739

3.  Effects of a new thromboxane A2-antagonist (ONO-3708) and a new leukotriene-antagonist (ONO-1078) on thromboxane A2 analogue-, leukotriene C4-, and D4-induced regional myocardial blood flow reduction.

Authors:  T Torii; Y Toki; N Hieda; Y Ito; K Okumura; H Hashimoto; T Ito; K Ogawa; T Satake
Journal:  Heart Vessels       Date:  1988       Impact factor: 2.037

4.  Glucocorticoids in myocardial and cerebral infarction.

Authors:  M Koltai; A Tósaki; I Leprán; L Szekeres
Journal:  Agents Actions       Date:  1986-01

5.  Renal vascular effects of leukotriene C4 in the isolated perfused kidney of the rat.

Authors:  J C Frölich; M Yoshizawa
Journal:  Br J Pharmacol       Date:  1987-10       Impact factor: 8.739

6.  Effects of exogenous prostaglandins on the release of leukotriene C4-like immunoreactivity and on coronary flow in indomethacin-treated anaphylactic guinea-pig hearts.

Authors:  U Aehringhaus; A Dembinska-Kiéc; B A Peskar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-07       Impact factor: 3.000

7.  Potentiation of leukotriene formation in pulmonary and vascular tissue.

Authors:  A M Lefer; D M Roth; D J Lefer; J B Smith
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-06       Impact factor: 3.000

Review 8.  Leukotrienes, allergy and inflammation.

Authors:  F P Nijkamp; J M Sitsen
Journal:  Pharm Weekbl Sci       Date:  1982-12-17

9.  Pharmacological modulation of endothelin-induced contraction of guinea-pig isolated airways and thromboxane release.

Authors:  J G Filep; B Battistini; P Sirois
Journal:  Br J Pharmacol       Date:  1991-07       Impact factor: 8.739

10.  Effect of exogenous 5,8,11,14,17-eicosapentaenoic acid on cardiac anaphylaxis.

Authors:  H Juan; B A Peskar; T Simmet
Journal:  Br J Pharmacol       Date:  1987-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.